AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 84 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,600 | -37.5% | 12,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $197,760 | +79.9% | 12,000 | 0.0% | 0.01% | +100.0% |
| Q1 2023 | $109,920 | -70.5% | 12,000 | -76.9% | 0.00% | -70.0% |
| Q4 2022 | $372,000 | +291.6% | 52,000 | +173.7% | 0.01% | +233.3% |
| Q3 2022 | $95,000 | +102.1% | 19,000 | 0.0% | 0.00% | +200.0% |
| Q2 2022 | $47,000 | -63.8% | 19,000 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $130,000 | +170.8% | 19,000 | +216.7% | 0.00% | +200.0% |
| Q4 2021 | $48,000 | -18.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $59,000 | +47.5% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $40,000 | -25.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | +35.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $40,000 | +33.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $30,000 | -37.5% | 6,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $48,000 | -68.2% | 6,000 | -68.4% | 0.00% | -66.7% |
| Q1 2020 | $151,000 | +5.6% | 19,000 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $143,000 | +81.0% | 19,000 | 0.0% | 0.01% | +66.7% |
| Q3 2019 | $79,000 | +43.6% | 19,000 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $55,000 | +96.4% | 19,000 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $28,000 | -42.9% | 19,000 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $49,000 | -41.0% | 19,000 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $83,000 | -29.1% | 19,000 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $117,000 | -15.8% | 19,000 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $139,000 | -55.4% | 19,000 | -50.0% | 0.01% | -16.7% |
| Q4 2017 | $312,000 | +56.8% | 38,000 | +100.0% | 0.01% | -14.3% |
| Q3 2017 | $199,000 | – | 19,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |